Huntington National Bank
AXSM icon

Huntington National Bank’s Axsome Therapeutics AXSM Stock Holding History

Huntington National Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.6K Sell
170
-100
-37% -$21.7K ﹤0.01% 1503
2026
Q1 		$45.6K Buy
270
+5
+2% +$864 ﹤0.01% 1374
2025
Q4 		$48.4K Buy
265
+37
+16% +$5.17K ﹤0.01% 1257
2025
Q3 		$27.7K Buy
228
+29
+15% +$3.27K ﹤0.01% 1481
2025
Q2 		$20.8K Buy
199
+14
+8% +$1.48K ﹤0.01% 1558
2025
Q1 		$21.6K Sell
185
-29
-14% -$3.3K ﹤0.01% 1491
2024
Q4 		$18.1K Sell
214
-1
-0.5% -$92 ﹤0.01% 1573
2024
Q3 		$19.3K Buy
215
+2
+0.9% +$175 ﹤0.01% 1521
2024
Q2 		$17.1K Sell
213
-123
-37% -$9.11K ﹤0.01% 1508
2024
Q1 		$26.8K Sell
336
-14
-4% -$1.18K ﹤0.01% 1375
2023
Q4 		$27.9K Buy
350
+2
+0.6% +$134 ﹤0.01% 1318
2023
Q3 		$24.3K Sell
348
-13
-4% -$972 ﹤0.01% 1296
2023
Q2 		$25.9K Buy
361
+45
+14% +$3.32K ﹤0.01% 1279
2023
Q1 		$19.5K Sell
316
-51
-14% -$3.35K ﹤0.01% 1323
2022
Q4 		$28.3K Buy
367
+36
+11% +$2.15K ﹤0.01% 1175
2022
Q3 		$14K Hold
331
– – ﹤0.01% 1419
2022
Q2 		$13K Hold
331
– – ﹤0.01% 1477
2022
Q1 		$14K Sell
331
-1
-0.3% -$31 ﹤0.01% 1476
2021
Q4 		$13K Sell
332
-75
-18% -$2.76K ﹤0.01% 1500
2021
Q3 		$13K Buy
407
+70
+21% +$2.73K ﹤0.01% 1366
2021
Q2 		$23K Buy
337
+63
+23% +$3.78K ﹤0.01% 1178
2021
Q1 		$16K Buy
+274
New +$19.3K ﹤0.01% 1202
2020
Q1 		– Sell
-500
Closed -$52K – 1538
2019
Q4 		$52K Buy
+500
New +$20.2K ﹤0.01% 925

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Huntington National Bank's AXSM Position: Q2 2026 in Review

Huntington National Bank reduced its Axsome Therapeutics (AXSM) stake by 37% in Q2 2026, selling an estimated $21.7K and leaving 170 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Huntington National Bank first reported a position in AXSM in Q4 2019 and has held it in 23 quarters since. The position peaked at $52K in Q4 2019. 507 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Huntington National Bank held 170 shares of Axsome Therapeutics worth $41.6K as of Q2 2026.
  • Huntington National Bank sold 100 Axsome Therapeutics shares in Q2 2026, an estimated $21.7K.
  • Axsome Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1503 holding.
  • Huntington National Bank first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 23 quarters since.
  • Huntington National Bank's Axsome Therapeutics position peaked at $52K in Q4 2019.
  • 507 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.